Skip to main content

Pichl Daniel's Form 4 filing

SpringWorks Therapeutics, Inc. (SWTX) · filed Feb 12, 2025

Accession no.
0001104659-25-012365
Filed
Feb 12, 2025
Trade date
Feb 10, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.62M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Pichl DanielCIK 0001819465Officer (Chief People Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 10, 2025Common StockMOption exerciseAcquired+13,750$27.64+$380,05064,512Direct
Feb 10, 2025Common StockMOption exerciseAcquired+16,000$27.64+$442,24080,512Direct
Feb 10, 2025Common StockSSaleDisposed−13,750$53.02−$729,02566,762Direct
Feb 10, 2025Common StockSSaleDisposed−9,000$54.25−$488,25057,762Direct
Feb 10, 2025Common StockSSaleDisposed−7,000$57.15−$400,05050,762Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 10, 2025Common StockMOption exerciseDisposed−13,750$0.00$031,250Direct
Feb 10, 2025Common StockMOption exerciseDisposed−16,000$0.00$032,750Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)